Literature DB >> 24228496

[Analysis of matrix Gla-protein (MGP) G-7A polymorphism association with ischemic atherothrombotic stroke in persons with risk factors].

O V Ataman, O V Polonikov, V Iu Harbuzova, Iu O Ataman, O I Matlaĭ.   

Abstract

G-7A polymorphism (rs1800801) of matrix Gla protein (MGP) gene in 170 patients with ischemic atherothrombotic stroke (IATS) and in 124 persons of the control group was determined. It was shown that in patients with IATS the distribution of the major allele homozygotes, heterozygotes and minor allele homozygotes was 35.9; 48.8; 15.3% (in control--43.5; 50.0; 6.5%, P = 0.051 by chi2-test). Significant differences in the distribution of genotypes were revealed only in women (P = 0.022). Odds ratio for minor allele homozygotes (A/A) versus major allele carriers (G/A+G/G) was 2,618 (P = 0.023), while in women it was equal to 6,645 (P = 0.015). In patients with A/A genotype the values of blood coagulation parameters (prothrombin time) indicated increased predisposition to hypercoagulability. The results obtained suggest that the A/A-variant of MGP gene is associated with an increased risk of IATS in female persons of the Ukrainian population and may be related to blood hypercoagulability and thrombi formation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24228496

Source DB:  PubMed          Journal:  Tsitol Genet        ISSN: 0564-3783


  2 in total

1.  Matrix Gla protein polymorphism rs1800801 associates with recurrence of ischemic stroke.

Authors:  Philipp Hendrix; Nelson Sofoluke; Matthew Adams; Saran Kunaprayoon; Ramin Zand; Amy N Kolinovsky; Thomas N Person; Mudit Gupta; Oded Goren; H Lester Kirchner; Clemens M Schirmer; Natalia S Rost; James E Faber; Christoph J Griessenauer
Journal:  PLoS One       Date:  2020-06-25       Impact factor: 3.240

Review 2.  Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.

Authors:  Stefanos Roumeliotis; Evangelia Dounousi; Theodoros Eleftheriadis; Vassilios Liakopoulos
Journal:  Int J Mol Sci       Date:  2019-02-01       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.